Status:
TERMINATED
Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Pruritus
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
The purpose of this study is determine if long acting antihistamine like cetirizine can help with itching induced by opioid pain medications.
Eligibility Criteria
Inclusion
- Children age 6-18yrs on opioids who develop pruritus and are willing to participate in the study
Exclusion
- Children with history of chronic urticaria
- Children with other chronic pruritic condition like eczema, contact dermatitis, psoriasis
- Children with known hypersensitivity to cetirizine/zyrtec
- Children on H1 antihistamine like diphenhydramine, hydroxyzine, cetirizine, loratadine, fexofenadine, chlorpheniramine within the last 7days prior to randomization
- Children who have received Ondansetron within 24hrs prior to randomization
- Children who are on Tricyclic antidepressants
- Children who are unwilling or unable to swallow the capsule.
- Children with chronic liver or kidney disease
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01825655
Start Date
September 1 2014
End Date
November 1 2017
Last Update
October 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Richmond at VCU
Richmond, Virginia, United States, 23298